In2Bones Overview
- Founded
-
2011
- Status
-
Private
- Employees
-
62
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$255M
- Investors
-
1
In2Bones General Information
Description
Operator of an orthopedic company intended to produce implants and instrumentation for the upper and lower extremities. The company leverages patented technology to develop fully pre-sterilized devices, and single-use instrument sets, and also provides a variety of products, enabling surgeons to alleviate pain and restore motion for their patients.
Contact Information
Website
www.in2bones.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Primary Office
- 6000 Poplar Avenue
- Suite 115
- Memphis, TN 38119
- United States
+1 (844) 000-0000
In2Bones Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 04-May-2022 | $255M | 000.00 | 00000 | Completed | Generating Revenue |
| 5. Later Stage VC | 03-May-2019 | 00.00 | 000.00 | Completed | Generating Revenue | |
| 4. Later Stage VC | 23-Oct-2017 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 3. Early Stage VC | 20-Oct-2015 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 2. Early Stage VC | 28-Feb-2014 | $4.09M | $5.47M | 0000 | Completed | Generating Revenue |
| 1. Angel (individual) | 22-Nov-2011 | $1.37M | $1.37M | Completed | Startup |
In2Bones Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
In2Bones Patents
In2Bones Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021357699-A1 | Osteochondral/subchondral treatment system | Pending | 05-Oct-2021 | ||
| CA-3194985-A1 | Osteochondral/subchondral treatment system | Pending | 06-Oct-2020 | 00000000000 | |
| US-20220039810-A1 | Metatarsal alignment apparatus | Pending | 10-Aug-2020 | 000000000 | |
| US-20220175436-A1 | Metatarsal alignment apparatus | Pending | 10-Aug-2020 | 000000000 | |
| US-20210378722-A1 | Bowed plate for fixating osteotomies and joint arthrodeses | Pending | 08-Jun-2020 | A61B17/846 | 0 |
In2Bones Executive Team (6)
In2Bones Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Bruce Lawrence | In2Bones | Chief Strategy Officer & Executive Chairman | 000 0000 |
| Dennis Long | Self | Board Member | 000 0000 |
In2Bones Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
In2Bones Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Edmond de Rothschild Corporate Finance | Investment Bank | Minority | 000 0000 | 000000 0 |